We have previously established the reliability and cross-sectional validity of the SIST-M (Structured Interview and Scoring Tool-Massachusetts Alzheimer's Disease Research Center), a shortened version of an instrument shown to predict progression to Alzheimer disease (AD), even among persons with very mild cognitive impairment (vMCI).
T he Clinical Dementia Rating (CDR) 1, 2 and CDR sumof-boxes (CDR-SB, the total of CDR ratings from 6 cognitive and functional domains) are effective in distinguishing cognitive status along the spectrum encompassing normal aging, mild cognitive impairment (MCI), and mild dementia. Indeed, the CDR is a mandatory element of the National Institute on Aging-funded Alzheimer's Disease Centers/Alzheimer's Disease Research Centers Uniform Data Set. 3 Formal CDR interview protocols 2 have been developed and an expanded interview 4 that yields high reliability and discriminative ability of the CDR within the range of even very mild cognitive change. In earlier study, we demonstrated that this expanded interview can predict the clinical course, even among very mildly impaired individuals who do not meet the formal MCI criteria as implemented in most clinical trials. 5 However, its average 90-minute administration time would preclude use in most larger-scale research settings, including multicenter clinical trials.
Therefore, we recently developed the Structured Interview and Scoring Tool-Massachusetts (SIST-M ADRC) 6 -a systematic, time-efficient method (approximately 25 min) for administering the CDR among very mildly impaired persons without sacrificing reliability. The SIST-M was found to have high reliability not only for the global CDR score, as has been achieved with worksheet scoring systems, 7 but also for the CDR-SB over a wide range of cognitive symptoms. Key strengths of the SIST-M include the following: (1) facilitation of reliable quantification of cognitive change, even among people with very mild levels of impairment-which may be of particular value in future trials of preventive interventions targeted at persons with very mild cognitive changes; (2) structuring of the interview and detailed symptom probes of the SIST-M-IR aid in obtaining reports on subtle cognitive changes; and (3) the independent-report format of the SIST-M-IR. We previously found that agreement between the SIST-M and expanded interview was good to superior for global CDR and CDR-SB. Our current objective was to evaluate whether the predictive validity of the SIST-M for the subsequent development of AD is comparable to that of the expanded clinician interview, particularly among participants in the spectrum of mild impairments-a critical group for early intervention studies. To achieve this, we utilized conventional survival analysis and newer methods of timedependent receiver operating curve (ROC) analysis. 8 
METHODS

Participants
Participants were drawn from a longitudinal study examining the preclinical predictors of AD that included nondemented patients demonstrating a range of cognitive and functional impairment. 9 Older men and women (n = 379) were recruited from the community in 3 successive cohorts through print advertisements indicating that a research study was seeking individuals both with and without memory difficulty (ie, rather than from a clinical or other medical referral source): cohort 1 (N = 165) from 1992 to 1993, cohort 2 (N = 119) from 1997 to 1998, and cohort 3 (N = 95) from 2002 to 2006. Volunteer respondents then underwent a multistage screening procedure. To be included, participants had to be 65 years or older (with the exception of 7 individuals aged 57 to 64 y); not have dementia; have a CDR rating of normal (CDR = 0) or mildly impaired (CDR = 0.5) 2 ; have a knowledgeable informant to provide collateral reports regarding cognitive symptoms; and have no significant underlying medical, neurological, or psychiatric illness (based on standard laboratory tests and a clinical evaluation). All participants and their informants provided informed consent at the time of enrollment in accordance with the guidelines of the Human Research Committee and Institutional Review Board of the Massachusetts General Hospital, Boston, Massachusetts.
Overview of Methods for Participant Assessment
At baseline, the study procedures included a medical evaluation (ie, medical history and physical examination, electrocardiogram, and standard blood tests, including extended chemistry, liver function tests, complete blood count, thyroid stimulating hormone, vitamin B12, and folate), the CDR interview, comprehensive neuropsychological testing, brain magnetic resonance imaging and single photon emission computed tomographic (SPECT) scans, and blood sample collection for genetic analysis. Thereafter, participants were followed annually with physical and neurological examinations, CDR interviews, and brief neuropsychological testing. Comprehensive neuropsychological testing, magnetic resonance imaging, and sometimes single photon emission computed tomography were repeated when participants crossed certain clinical thresholds, including the development of dementia.
Clinical Interviews
An expanded, semistructured interview was administered at baseline, and annually thereafter, to assess the degree of clinical impairment and to generate an overall CDR rating and CDR-SB. 4 Each interview was administered by a skilled clinician (eg, psychiatrist, neurologist, psychologist, or physician's assistant) and took approximately 90 minutes to complete. The mean interrater reliability of the overall CDR ratings was high (R = 0.99, P<0.0001), as was the interrater reliability (RZ0.90) of the 6 CDR subcategories (memory, orientation, judgment and problem-solving, community affairs, home and hobbies, and personal care). 4
Application of the SIST-M Algorithm
We recently developed the SIST-M 6 (available at http://madrc.mgh.harvard.edu/structured-interview-scoringtool-massachusetts-adrc-sist-m), which features 60 items derived from the larger set of 131 items in the expanded interview 4 ; each SIST-M item can be graded using the same ordinal categories that denote no-to-mild symptoms on the CDR (eg, 0, 0.5, 1). A computer algorithm was created in a development cohort [n = 147 of 165 participants in cohort 1; 18 participants had data missing on the expanded (131-item) questionnaire] to facilitate validity testing. This algorithm is a complex, hierarchical design that uses a combination of the grade of each item (ie, 0, 0.5, 1), the frequency with which different grades of items were observed within a CDR domain (or its key subdomains), and the relative clinical importance, or "weight," of select items. Thus, the computer algorithm simulates, in effect, what would have happened if the clinician interviews had been conducted using only the 60 items of the SIST-M. Additional details of the development of this algorithm are provided elsewhere. 6 High concordance of algorithm-based CDR-SB with original raters' CDR-SB was confirmed in a replication cohort (n = 200 of 214 participants in cohorts 2 and 3; 14 participants had missing data on the expanded questionnaire): intraclass correlation coefficient [95% confidence interval (CI)] = 0.89 (0.86, 0.91). 6 
Neuropsychological Testing
At baseline, a 22-test neuropsychological battery was administered to all participants, as described previously. 9 Component tests included several measures of episodic memory, such as the California Verbal Learning Test Total Learning and Delayed Retention scores 10 and the Free and Cued Selective Reminding Test, 11 and tests of general cognitive function [Mini-Mental State Exam (MMSE) 12 ], executive function (Trail Making Test 13 ), working memory, and phonemic fluency. The neuropsychological battery was administered in a separate session from the clinical evaluation described above, and was scored in a blinded manner with respect to CDR ratings or diagnostic information.
Using baseline data from the entire sample, we performed a linear regression for each neuropsychological test score using age, sex, and educational attainment as predictors, and saved the residuals from this regression. Among participants who were cognitively normal at baseline (ie, global CDR = 0.0), we computed the mean and standard deviation of these residuals. Standardized scores-or z scores-were then calculated for all participants, using the mean and standard deviation of the score distribution of normal participants. Thus, a z score of À1.0 indicates that the participant's performance was 1 standard deviation below the expected mean for a cognitively intact person of the same age, sex, and education level.
Sample for Analysis
Of the 379 longitudinal study participants, we had data available to generate algorithm-based CDR ratings for 347 persons. In addition, we excluded 5 participants who did not have at least 1 follow-up visit after baseline (n = 4) (ie, follow-up time = 0) or had an incomplete baseline MMSE (n = 1). Thus, the final sample for analysis was 342.
Cognitive Status Groupings at Baseline
In our sample, the distribution of CDR-SB scores at baseline was broad, whether CDR-SB scores were based on clinician-based or algorithm-based ratings. Individuals at the more impaired end of the spectrum (ie, CDR-SBZ2.0) seemed comparable to MCI patients recruited from clinicbased settings, based on similar likelihood of progression to a diagnosis of AD. 4 However, at the mild end of the spectrum (ie, CDR-SB = 0.5 to 1.5), many participants did not meet the psychometric cut-offs commonly used to define amnestic MCI in epidemiologic studies and clinical trials 14, 15 ; such persons were considered to have very mild cognitive impairment (vMCI). 5, 16 Other groups have used similar terms-that is, pre-MCI 16 -to denote the presence of consistent and meaningful changes in subjective and/or informant-reported cognitive abilities without the presence of objective deficits meeting the criteria for MCI; in current Uniform Data Set 3 terminology, the cognitive status of participants with vMCI would be categorized as "impaired, not MCI." 3 The classification of baseline cognitive status was operationalized using a method detailed elsewhere 5 and summarized here:
Normal: CDR global rating = 0.0. MCI: CDR global rating = 0.5 and Subjective memory complaint by participant and/or informant: Z0.5 rating in memory; Evidence of preserved general cognitive function: MMSE Z24; Intact basic and instrumental activities of daily living: r0.5 ratings in community affairs, homeand-hobbies, and personal care. Objective memory deficit: r1 SD below the ageadjusted, sex-adjusted, and education-adjusted mean of normal participants' scores on the California Verbal Learning Test delayed free recall trial; vMCI: those who otherwise met the criteria for MCI (ie, symptoms), but did not meet the cognitive testing requirement.
Thus, 2 baseline cognitive status classifications could be generated for each participant: one based on clinicians' original CDR ratings and the neuropsychological test results, and another generated from algorithm-based CDR ratings and the neuropsychological test results. Four participants who otherwise met the criteria for MCI but had ratings Z1.0 on community affairs, home-andhobbies, or personal care were excluded from analyses using these cognitive status classifications.
Procedures for Diagnosis During Follow-up
A consensus diagnosis was assigned to participants who developed significant cognitive and functional impairment at an annual follow-up visit; this consensus method incorporated clinical history, medical records, laboratory evaluation, and neuroimaging studies, and is detailed elsewhere. 9 Individuals with dementia were classified as AD or another diagnosis (eg, frontotemporal dementia, vascular dementia) according to standard clinical research criteria. [17] [18] [19] 
Statistical Analyses
Using prospective data on the development of AD among participants in both the development and replication cohorts, we evaluated how well the CDR-SB predicted AD diagnosis over follow-up. In survival analyses, we examined CDR-SB as a predictor using the clinicians' scores and, separately, using the algorithm-based CDR-SB scores. Using traditional methods of survival analysis, we examined predictive validity in the full sample and in the 3 cognitive status subgroups of normal, vMCI, and MCI defined according to clinician-based or algorithm-based CDR ratings.
First, separate Kaplan-Meier curves were constructed to estimate the AD survival times as baseline evaluation in the normal, vMCI, and MCI groups. In each condition (ie, clinician-based or algorithm-based baseline cognitive status groupings), the log-rank test was used to compare the survival times among the 3 groups.
Second, we used the Cox proportional hazards method to allow for variable follow-up lengths and estimated the hazard ratio of AD using the CDR-SB score as the predictor. The primary focus of the analyses was time from baseline evaluation to the diagnosis of AD or censoring; censoring events were death, loss-to-follow-up, or development of non-AD dementia. Two sets of models were created: one using the clinicians' CDR-SB scores and the other using the algorithm-based CDR-SB scores. In addition, Cox models were developed to evaluate the prediction of AD in the full sample and separately among 156 participants jointly classified as vMCI by both clinician-based and algorithm-based CDR ratings (note that 32 vMCI participants were excluded from these analyses: 18 who met the vMCI criteria by clinician but not algorithm-based CDR ratings and 14 who met the criteria by algorithm but not clinician-based ratings; see Result section). All Cox models were adjusted for age (at baseline evaluation), sex, and education; age and education were treated linearly because there was no evidence of a nonmonotonic relationship between these variables and the log-hazard estimates of AD conversion. The proportionality assumption was confirmed by plotting the lognegative-log of the estimated survival distribution against the log of the follow-up time. As the sets of models using either the clinicians' or the algorithm-based CDR-SB scores were non-nested, model fit could not be compared using likelihood ratio tests; instead, model fit was compared using Akaike information criteria (AIC), 20, 21 which is a commonly used measure for comparison of competing models (the model that produces the minimum AIC is preferred). 21 All traditional survival analyses were conducted using SAS version 9.1 (SAS Institute, Cary, NC).
Finally, to further evaluate the predictive ability of clinician-based versus algorithm-based CDR-SB among all participants across the entire follow-up period, we applied a newer statistical approach to characterize the predictive accuracy of clinician-based versus algorithm-based CDR-SB: ROC curve methods for time-dependent outcomes (ie, time-to-AD as a censored survival time). 8 This time-dependent ROC method utilizes concepts of incident sensitivity (IS) and dynamic specificity (DS). IS at time t measures the expected fraction of participants with a "marker" value >M among the subpopulation of individuals who progress to AD at time t. DS at time t measures the expected fraction of participants with a "marker" value rM among the subpopulation of individuals who have not progressed to AD by time t. The marker is a linear combination of estimated regression parameters and covariates (age, sex, years of education, and either the clinician CDR-SB or the algorithm-based one) derived from the Cox model. In this context, M is a marker threshold. Thus, IS and DS are defined by dichotomizing the risk set at time t into those who progress and those who do not. The corresponding ROC curve at time t depicts IS versus DS at time t over a set of thresholds. A scalar summary for the ROC curve at time t is the areaunder-the-ROC curve (AUC) at time t. Moreover, a global scalar that summarizes the sequence of time-dependent AUCs over the follow-up time is a weighted average of the AUCs and has interpretation as the concordance probability. 8 This concordance probability, C, related to Kendall t measure of bivariate correlation, measures the predictive accuracy of a marker for an event that occurs at random times and may be right-censored. C reflects the probability that, for a pair of participants, the person who progressed earlier to AD has a larger value of the marker:
where M i and T i denote the values of the marker and the survival time for the i th individual, and where it is assumed that a higher marker value is predictive of a poor prognosis. Therefore, C will reflect the probability that the predictions using this marker for a random pair of participants are concordant with their outcomes-that is, how well the marker predicts earlier progression to AD. In our study, M 1 and M 2 are marker values obtained from the Cox models using clinician CDR-SB and algorithm-based CDR-SB, respectively; C 1 and C 2 are the respective concordance summaries obtained using M 1 and M 2 . The 95% CIs for the difference between the 2 concordance summaries were derived using the percentile bootstrap method 22 and accounted for their correlation due to being calculated on the same subjects. Thus, using the time-dependent ROC curve methodology, we were able to make a direct statistical comparison between original and algorithmic CDR-SB on predictive accuracy for AD over the entire range of follow-up time. These time-dependent ROC analyses were conducted using R (R Foundation for Statistical Computing, Vienna, Austria). Table 1 illustrates participants' demographic and clinical characteristics, by diagnostic grouping. Members of the normal group were several years younger, on average, than those in the MCI group and slightly younger than persons with vMCI. There were no group differences in sex or education. Not surprisingly, cognitively normal participants had better performance on all neuropsychological measures than the MCI group; however, their performance was comparable to that of participants with vMCI on most measures. *For the purposes of Table 1 , baseline cognitive status groups were determined using clinicians' Clinical Dementia Rating scores, rather than the algorithmbased ones.
RESULTS
Demographic and Clinical Characteristics of the Sample
MCI indicates mild cognitive impairment (see text under Methods for operationalized definitions of these terms); SD, standard deviation; vMCI, very mild cognitive impairment.
Classification of Baseline Cognitive Status by Clinician-based and Algorithm-based CDR Ratings
Agreement of cognitive status classifications using clinicians' versus algorithm-based CDR scores was high; the weighted kappa (k) for agreement was 0.84 (95% CI = 0.78, 0.91). Further, on reclassifying to MCI, for the 4 participants who otherwise met the criteria for MCI but who had either clinician-based or algorithm-based CDR ratings Z1.0 in community affairs, home and hobbies, or personal care (ie, "MCI-plus"), agreement was again high (weighted k = 0.85; 95% CI = 0.79, 0.91). (Data not shown in table).
Result From Traditional Survival Analysis
Results from the adjusted Cox proportional hazards models demonstrated similar findings in models utilizing clinician versus algorithm-based ratings ( Table 2 ). The clinician-based model fit the data slightly better than the algorithm-based model (ie, lower AIC); however, AD hazard ratios were the same: for a 1-point increment in baseline CDR-SB, there was a 3-fold increase in the hazard. Within the vMCI group, the estimated 2-fold increases in the hazard associated with each 1-point increase in CDR-SB were similar; model fit was identical. Finally, as would be expected, given the similar CDR ratings, the Kaplan-Meier curves of the 3 cognitive status groups looked identical, whether the groups were based on clinician or algorithm-based CDR scores (Fig. 1) .
Results From Time-dependent ROC Analysis
The AUCs over follow-up were informative (Fig. 2) . Concordance probabilities (global values for the weighted average of the AUCs over the follow-up period) were similar using original (concordance probability = 0.78; 95% CI = 0.74, 0.82) and algorithmic (concordance probability = 0.76; 95% CI = 0.72, 0.80) CDR-SBs. The estimated difference between concordance probabilities was 0.02 (95% CI, À0.01, 0.05). Thus, the CI for the difference contained zero-indicating that the data did not provide evidence of a statistical difference in concordance probabilities (which measure the predictive accuracy of AD development over the entire range of follow-up). Furthermore, on restricting analysis to the replication cohort, concordance probabilities (95% CI) were 0.79 (0.73, 0.85) using original CDR-SB and 0.78 (0.72, 0.84) using algorithmic CDR-SB; the estimate for the difference between concordance probabilities contained 0: 0.015 (95% CI, À0.03, 0.05). Interestingly, on visual inspection of Figure 2 , the original CDR-SB seemed to have a higher concordance probability for short-term predictions; however, for longer-term predictions, original clinician-based and algorithm-based CDR-SBs seemed comparable. However, we separately calculated the difference in the concordance probabilities for the first 2 and 3 years of follow-up, and there was no statistical evidence of a difference in predictive accuracy: estimated differences (comparing original vs. algorithmic CDR-SBs) were 0.017 (95% CI, À0.03, 0.06) in the first 2 years and 0.013 (95% CI, À0.03, 0.05) in the first 3 years. Similarly, on restricting analysis to the replication cohort, estimated differences were 0.011 (95% CI, À 0.05, 0.06) in the first 2 years and À0.006 (95% CI, À 0.06, 0.05) in the first 3 years. Finally, among the 156 participants jointly classified as vMCI, concordance probabilities (95% CI) were 0.72 (0.66, 0.79) using original CDR-SB and 0.71 (0.66, 0.078) using algorithmic CDR-SB; the estimated difference was 0.005 (95% CI, À 0.04, 0.05)-demonstrating that, similar to findings from the traditional survival analyses, there was no 
DISCUSSION
The SIST-M was recently developed as a time-efficient structured interview that can be used to generate CDR scores that are reliable and discriminate along the spectrum of mild cognitive deficits 6 ; we previously identified high reliability and cross-sectional validity for this instrument. In the current report, we demonstrate that the instrument has high predictive validity-identical to that of the lengthier expanded interview 5 -even among those with the mildest cognitive symptoms.
The strengths of this study include development of the SIST-M within a well-characterized, community-based sample of older adults with a broad range of mild cognitive symptoms, established reliability of the SIST-M, and prospective design with a lengthy follow-up (mean = 7.4 y, SD = 4.0, range = 1.0 to 14.2). Furthermore, we utilized the time-dependent ROC methodology to verify that high predictive accuracy of baseline CDR-SB scores was maintained over the length of the follow-up period, using either the shorter or the longer interview format. A powerful advantage of this newer statistical method of time-dependent ROC analysis is that it facilitates a direct statistical comparison of the clinician-based and algorithm-based CDR-SB scores with respect to predictive accuracy over the entire range of followup time. In addition, the use of this method is attractive because of the familiarity and interpretability of the ROC concept for most clinical research audiences.
Limitations must also be recognized. First, prediction using the SIST-M was based on an algorithmic computer simulation of clinician judgment, not actual in-person interviews. Nevertheless, the high concordance of clinician versus algorithm-based CDR ratings and CDR-SB 6 suggests little loss of information. Second, predictive validity was evaluated in a cohort of well-educated, mostly white elders who were aged 57 to 87 years at baseline; thus, the generalizability of the SIST-M to less-educated, racial/ ethnic minority, or oldest-old populations is unclear. Nevertheless, the characteristics of our cohort are consistent with those observed nationally in many other Alzheimer's Disease Centers/Alzheimer's Disease Research Centers, and it is likely that the SIST-M would perform equally well at other sites with respect to the prediction of clinical progression. Third, there is likely some inflation of the concordance probabilities in the time-dependent ROC curve analyses, due to our deriving the marker using the same data on which we assessed it. However, this is equally true for both the clinician-based and the algorithm-based CDR-SB, and so the conclusions regarding their comparison are valid. Finally, dementia diagnoses were not all autopsy-confirmed. Nevertheless, criteria-based diagnoses of probable AD, when made by skilled physicians, are known to be approximately 90% accurate, compared with pathologic diagnoses. 17 In summary, the validity of the SIST-M in generating CDR-SB scores is supported by its high predictive validity for the development of AD. Furthermore, these results support the value of the CDR-SB in grading subtle deficits among cognitively impaired persons, even in the setting of vMCI. Thus, the SIST-M may be particularly valuable in efficiently generating CDR scores where research interest is targeted on recruiting and characterizing samples of very mildly impaired individuals for prevention, early intervention, or disease-modifying trials, or where clinical attention is focused on assessment of primary care patients and community-based individuals who might benefit from an early intervention of novel therapeutic agents.
